Glycine

CHEMBL773 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
75.1 g/mol
LogP
-3.2
Phase
4

The simplest amino acid, used as a nutritional supplement and investigated for potential roles in treating neurological conditions such as Alzheimer's disease and bipolar disorder by modulating NMDA receptor activity in the brain. It serves as an inhibitory neurotransmitter in the spinal cord and brainstem and participates in the synthesis of proteins, creatine, and porphyrins. Research continues to explore its therapeutic potential across multiple conditions.

Peso Molecular

75,0700 g/mol

LogP

-3,20

TPSA

63,30 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NCC(=O)O

InChI

InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)

Molecular Formula

C2H5NO2

HBD / HBA

2 / 3

Ligações Rotacionáveis

1

Átomos Pesados

5

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The simplest amino acid, used as a nutritional supplement and investigated for potential roles in treating neurological conditions such as Alzheimer's disease and bipolar disorder by modulating NMDA receptor activity in the brain. It serves as an inhibitory neurotransmitter in the spinal cord and brainstem and participates in the synthesis of proteins, creatine, and porphyrins. Research continues to explore its therapeutic potential across multiple conditions.

Yes, Glycine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL773. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 750. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.